Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibody and checkpoint inhibitor combination therapy

Antibody and checkpoint inhibitor combination therapy

US Patent 11655304 · Granted May 23, 2023

Estimated economic value: $169,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for treating acute myeloid leukemia2022
Method of treating cancer by administering an anti-LGR5 monoclonal antibody2020
Methods of blocking cancer stem cell growth2020
Humanized antibodies that bind LGR52019
Methods of inhibiting growth of a colon cancer tumor in a subject by administeri2019
Antibodies that bind LGR4, their use in inhibiting neoplastic cells and in treat2017
Humanized antibodies that bind LGR52017
Methods of treating cancer by administering anti-GPR49 antibodies2015
Methods of inhibiting solid tumor growth by administering GPR49 antibodies2015
Anti-GPR49 monoclonal antibodies2015
Anti-IGR-1R antibodies and uses thereof2012
Compositions and methods for angiogenesis-related molecules and treatments2010